Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using Vorinostat

Review the clinical trials studying vorinostat on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-6 of 6

A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects
Status: Active
Location: 15 locations
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Status: Active
Location: 7 locations
Total Therapy for Infants with Acute Lymphoblastic Leukemia, The TINI 2 Study
Status: Active
Location: 6 locations
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Mirdametinib and Vorinostat for the Treatment of Neurofibromatosis Type 1 and Histone H3 Lysine 27 Trimethylation-Negative Malignant Peripheral Nerve Sheath Tumors
Status: Active
Location: University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota
Venetoclax to Augment Epigenetic Modification and Chemotherapy
Status: Active
Location: See ClinicalTrials.gov